All eyes were on a new instrument launch, which got off to a strong start judging from pre-orders.
News & Analysis: Nanostring Technologies
NSTG earnings call for the period ending June 30, 2019.
Investors will be focused on a potentially trajectory-altering product launch, but it will be several quarters (at least) before we can start drawing conclusions about its impact.
Investors are excited (perhaps a little too excited) about a new opportunity in immuno-oncology.
NSTG earnings call for the period ending March 31, 2019.
NSTG earnings call for the period ending December 31, 2018.